Literature DB >> 6822617

Effects of topical application of a calcium antagonist (nifedipine) on feline cortical pial microvasculature under normal conditions and in focal ischemia.

L Brandt, B Ljunggren, K E Andersson, L Edvinsson, E MacKenzie, A Tamura, G Teasdale.   

Abstract

Cat cortical arterioles and venules were exposed in vivo to the Ca2+ antagonist nifedipine under normal conditions and in focal ischemia. Topical application of nifedipine caused a marked, concentration-dependent arteriolar dilatation. The dilatatory responses increased significantly with decreasing arteriolar size. Perivenular microapplication of nifedipine invariably caused dilatation that was less pronounced but more long-lasting than that on the arteriolar side. Arterioles, which constricted after middle cerebral artery occlusion, invariably dilated following nifedipine application. These dilatatory responses were transient but could be repeated, and on some occasions were accompanied by a return of flow in vessels in which stasis had been present. The results suggest that nifedipine is able to dilate cerebral vessels both under normal conditions and when contracted during focal ischemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822617     DOI: 10.1038/jcbfm.1983.5

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  11 in total

Review 1.  Aneurysmal subarachnoid hemorrhage: prevention of delayed ischemic dysfunction with intravenous nimodipine.

Authors:  B Ljunggren; L Brandt; H Säveland; B Romner; T Ryman; K E Andersson
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

Review 2.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 3.  Drug treatment of stroke. Current status and future prospects.

Authors:  C A Sila; A J Furlan
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

4.  Effects of a Ca2+ entry blocker (nilvadipine) on acute focal cerebral ischemia in rats.

Authors:  S Kawamura; N Yasui; M Shirasawa; H Fukasawa
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

5.  Rupture of a cerebral aneurysm associated with nifedipine treatment.

Authors:  J S Gill; A V Zezulka; P M Horrocks
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

6.  Oral nimodipine reduces prostaglandin and thromboxane production by arteries chronically exposed to a periarterial haematoma and the antifibrinolytic agent tranexamic acid.

Authors:  J D Pickard; V Walker; J Vile; S Perry; P J Smythe; R Hunt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

Review 7.  Microcirculation and neurotransmitter metabolism in the pathophysiology of brain ischaemia. A role for calcium.

Authors:  M S Magnoni; S Govoni; M Trabucchi
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Therapeutic effects of nilvadipine on rat focal cerebral ischemia.

Authors:  Y Li; S Kawamura; N Yasui; M Shirasawa; H Fukasawa
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

9.  Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.

Authors:  Shintaro Gomi; Mark G Burnett; Andrea Karp; Joel H Greenberg
Journal:  Exp Brain Res       Date:  2004-01-30       Impact factor: 1.972

10.  Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.

Authors:  J D Pickard; G D Murray; R Illingworth; M D Shaw; G M Teasdale; P M Foy; P R Humphrey; D A Lang; R Nelson; P Richards
Journal:  BMJ       Date:  1989-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.